Viewing Study NCT00606502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-06 @ 2:06 AM
Study NCT ID: NCT00606502
Status: COMPLETED
Last Update Posted: 2021-03-05
First Post: 2008-01-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Sponsor: Spectrum Pharmaceuticals, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Stage IIIB/IV non-small cell lung cancer View
None Non-small cell lung cancer View
None NSCLC View
None Lung Cancer View
None Pralatrexate View
None Erlotinib View
None Tarceva View
None PDX View
None Smoking View
None Smoker View